• BG - български
  • EN - English
Parliamentary question - P-003713/2017(ASW)Parliamentary question
P-003713/2017(ASW)

Answer given by President Juncker on behalf of the Commission

1+2. The Commission would refer the Honourable Member to the Procedure leading up to a decision on the relocation of the European Medicines Agency and the European Banking Authority, endorsed by the Heads of State or Government of 27 Member States in the margins of the European Council (Article 50) held on 22 June 2017[1].

3. As regards the bearing of the costs of the relocation, point III.2 of the directives for the negotiation of an agreement with the United Kingdom[2] states that ‘the United Kingdom should fully cover the specific costs related to the withdrawal process such as the relocation of the agencies or other Union bodies’. No relevant estimate of the cost of the relocation can be made at this time because essential factors remain to be established.